Data On Novel Antibiotic Drugs That Mimic Humans’ Natural Defense Mechanisms Presented At ICAAC Meeting
With many strains of bacteria now immune to multiple classes of antibiotics, the needs for creating new germ fighters are enormous. Pioneering biotechnology companies are developing products that take the wiliness of bacterial superbugs into account, effectively performing an end-run around conventional antibiotics.
More: continued here
Filed under: Conferences on October 29th, 2008